Published in Phytomedicine on August 13, 2009
Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng (2007) 2.10
Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res (2003) 1.78
Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials (2006) 1.55
Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells (2005) 1.32
Osteoinduction of human mesenchymal stem cells by bioactive composite scaffolds without supplemental osteogenic growth factors. PLoS One (2011) 1.23
Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng (2002) 1.19
Tissue engineering and cell therapy of cartilage and bone. Matrix Biol (2003) 1.15
Orderly osteochondral regeneration in a sheep model using a novel nano-composite multilayered biomaterial. J Orthop Res (2010) 1.14
Design of graded biomimetic osteochondral composite scaffolds. Biomaterials (2008) 1.12
Cell therapy for bone disease: a review of current status. Stem Cells (2003) 1.07
Bone marrow stromal cells and their use in regenerating bone. Novartis Found Symp (2003) 1.03
Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2012) 1.02
Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci (2003) 1.02
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease. Haematologica (2011) 0.97
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals. Neuropharmacology (2009) 0.91
Sustainable production of biologically active molecules of marine based origin. N Biotechnol (2013) 0.91
Bone invading NSCLC cells produce IL-7: mice model and human histologic data. BMC Cancer (2010) 0.90
Chondrogenesis of mesenchymal stem cells in an osteochondral environment is mediated by the subchondral bone. Tissue Eng Part A (2013) 0.90
Fluorescence microscopy imaging of bone for automated histomorphometry. Tissue Eng (2002) 0.89
Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng Part A (2010) 0.88
Antimicrobial activity of the ornamental species Salvia corrugata, a potential new crop for extractive purposes. J Agric Food Chem (2008) 0.88
Order versus Disorder: in vivo bone formation within osteoconductive scaffolds. Sci Rep (2012) 0.86
Regulation of human mesenchymal stem cell functions by an autocrine loop involving NAD+ release and P2Y11-mediated signaling. Stem Cells Dev (2010) 0.85
FGF, TGFβ and Wnt crosstalk: embryonic to in vitro cartilage development from mesenchymal stem cells. J Tissue Eng Regen Med (2013) 0.84
A simple non invasive computerized method for the assessment of bone repair within osteoconductive porous bioceramic grafts. Biotechnol Bioeng (2005) 0.84
Osteogenic potential of rat spleen stromal cells. Eur J Cell Biol (2003) 0.84
Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysis. J Cell Biochem (2004) 0.83
DLX5 overexpression impairs osteogenic differentiation of human bone marrow stromal cells. Eur J Cell Biol (2008) 0.83
Phytotoxic clerodane diterpenes from Salvia miniata Fernald (Lamiaceae). Phytochemistry (2010) 0.81
A chemical proteomics approach reveals Hsp27 as a target for proapoptotic clerodane diterpenes. Mol Biosyst (2012) 0.80
Osteogenic differentiation of human mesenchymal stromal cells on surface-modified titanium alloys for orthopedic and dental implants. Int J Artif Organs (2009) 0.79
New flavonoid glycosides from Vernonia ferruginea. Nat Prod Commun (2009) 0.79
Total phenolic content and antioxidant activity of Salvia spp. exudates. Nat Prod Commun (2012) 0.79
Cancer chemopreventive diterpenes from Salvia corrugata. Phytochemistry (2013) 0.78
Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells. Hum Immunol (2006) 0.78
Demethyl fruticulin A (SCO-1) causes apoptosis by inducing reactive oxygen species in mitochondria. J Cell Biochem (2010) 0.78
A composite material model for improved bone formation. J Tissue Eng Regen Med (2010) 0.78
Differential gene expression of the intermediate and outer interzone layers of developing articular cartilage in murine embryos. Stem Cells Dev (2014) 0.78
Preparation, characterisation and preliminary antitumour activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and N-trimethyl chitosan. Invest New Drugs (2009) 0.78
MgCHA particles dispersion in porous PCL scaffolds: in vitro mineralization and in vivo bone formation. J Tissue Eng Regen Med (2012) 0.77
Composite electrospun nanofibers for influencing stem cell fate. Methods Mol Biol (2013) 0.77
The influence of plasma technology coupled to chemical grafting on the cell growth compliance of 3D hydroxyapatite scaffolds. J Mater Sci Mater Med (2012) 0.77
Hydroxyapatite-coated polycaprolacton wide mesh as a model of open structure for bone regeneration. Tissue Eng Part A (2009) 0.77
A three-dimensional traction/torsion bioreactor system for tissue engineering. Int J Artif Organs (2010) 0.76
In vivo lamellar bone formation in fibre coated MgCHA-PCL-composite scaffolds. J Mater Sci Mater Med (2011) 0.76
First evidence for an anxiolytic effect of a diterpenoid from Salvia cinnabarina. Nat Prod Commun (2009) 0.76
Defining an optimal stromal derived factor-1 presentation for effective recruitment of mesenchymal stem cells in 3D. Biotechnol Bioeng (2014) 0.76
Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production. Cytotechnology (2014) 0.76
Effect of a diterpenoid from Salvia cinnabarina on arterial blood pressure in rats. Phytother Res (2007) 0.76
Isolation of hydroxyoctaprenyl-1',4'-hydroquinone, a new octaprenylhydroquinone from the marine sponge Sarcotragus spinosulus and evaluation of its pharmacological activity on acetylcholine and glutamate release in the rat central nervous system. Nat Prod Commun (2014) 0.75
New compounds from an extract of Vernonia colorata leaves with anti-inflammatory activity. J Nat Prod (2004) 0.75
Phytotoxic activity of Salvia x jamensis. Nat Prod Commun (2009) 0.75
A comparative evaluation between new ternary zirconium alloys as alternative metals for orthopedic and dental prosthetic devices. Int J Artif Organs (2014) 0.75
A diterpenoid from Salvia cinnabarina inhibits mouse intestinal motility in vivo. Planta Med (2004) 0.75
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system. Neurochem Int (2013) 0.75
Chemical composition and antimicrobial activity of Salvia x jamensis essential oil. Nat Prod Commun (2012) 0.75
C-type natriuretic peptide: Structural studies, fragment synthesis, and preliminary biological evaluation in human osteosarcoma cell lines. Biopolymers (2010) 0.75
A secoisopimarane diterpenoid from Salvia cinnabarina inhibits rat urinary bladder contractility in vitro. Planta Med (2004) 0.75
A novel scaffold geometry for chondral applications: theoretical model and in vivo validation. Biotechnol Bioeng (2014) 0.75
Differences in chemical composition and internal structure influence systemic host response to implants of biomaterials. Int J Artif Organs (2011) 0.75
Nano-approaches in cartilage repair. J Appl Biomater Biomech (2010) 0.75
Relative stereochemistry of a diterpene from Salvia cinnabarina. Molecules (2007) 0.75
Rheological properties, biocompatibility and in vivo performance of new hydrogel-based bone fillers. Biomater Sci (2016) 0.75
Diterpenoids from Salvia wagneriana. Planta Med (2004) 0.75
Cell therapy: filling the gap between basic science and clinical trials October 15-17, 2001, Rome, Italy. Stem Cells (2003) 0.75
Salvia x jamensis J. Compton: Trichomes, essential oil constituents and cytotoxic-apoptotic activity. Nat Prod Res (2012) 0.75